These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15607664)

  • 1. Infection in permanent circulatory support: experience from the REMATCH trial.
    Holman WL; Park SJ; Long JW; Weinberg A; Gupta L; Tierney AR; Adamson RM; Watson JD; Raines EP; Couper GS; Pagani FD; Burton NA; Miller LW; Naka Y;
    J Heart Lung Transplant; 2004 Dec; 23(12):1359-65. PubMed ID: 15607664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe.
    Pae WE; Connell JM; Adelowo A; Boehmer JP; Korfer R; El-Banayosy A; Hetzer R; Vigano M; Pavie A;
    J Heart Lung Transplant; 2007 Mar; 26(3):219-29. PubMed ID: 17346623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial.
    Dembitsky WP; Tector AJ; Park S; Moskowitz AJ; Gelijns AC; Ronan NS; Piccione W; Holman WL; Furukawa S; Weinberg AD; Heatley G; Poirier VL; Damme L; Long JW
    Ann Thorac Surg; 2004 Dec; 78(6):2123-9; discussion 2129-30. PubMed ID: 15561049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices.
    Argenziano M; Catanese KA; Moazami N; Gardocki MT; Weinberg AD; Clavenna MW; Rose EA; Scully BE; Levin HR; Oz MC
    J Heart Lung Transplant; 1997 Aug; 16(8):822-31. PubMed ID: 9286774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
    Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
    J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy?
    Levy WC; Mozaffarian D; Linker DT; Farrar DJ; Miller LW;
    J Heart Lung Transplant; 2009 Mar; 28(3):231-6. PubMed ID: 19285613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
    Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era.
    Miller LW; Nelson KE; Bostic RR; Tong K; Slaughter MS; Long JW
    J Heart Lung Transplant; 2006 Jul; 25(7):778-84. PubMed ID: 16818120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular device as destination therapy: are we there yet?
    Badiwala MV; Rao V
    Curr Opin Cardiol; 2009 Mar; 24(2):184-9. PubMed ID: 19532106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.
    Dang NC; Topkara VK; Mercando M; Kay J; Kruger KH; Aboodi MS; Oz MC; Naka Y
    J Heart Lung Transplant; 2006 Jan; 25(1):1-6. PubMed ID: 16399523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support.
    Zierer A; Melby SJ; Voeller RK; Guthrie TJ; Ewald GA; Shelton K; Pasque MK; Moon MR; Damiano RJ; Moazami N
    Ann Thorac Surg; 2007 Aug; 84(2):515-20. PubMed ID: 17643627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between renal function and left ventricular assist device use.
    Butler J; Geisberg C; Howser R; Portner PM; Rogers JG; Deng MC; Pierson RN
    Ann Thorac Surg; 2006 May; 81(5):1745-51. PubMed ID: 16631666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of left ventricular assist device infection on post-transplant outcomes.
    Schulman AR; Martens TP; Russo MJ; Christos PJ; Gordon RJ; Lowy FD; Oz MC; Naka Y
    J Heart Lung Transplant; 2009 Mar; 28(3):237-42. PubMed ID: 19285614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable LVAD infections: implications for permanent use of the device.
    McCarthy PM; Schmitt SK; Vargo RL; Gordon S; Keys TF; Hobbs RE
    Ann Thorac Surg; 1996 Jan; 61(1):359-65; discussion 372-3. PubMed ID: 8561605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device.
    Topkara VK; Dang NC; Barili F; Cheema FH; Martens TP; George I; Bardakci H; Oz MC; Naka Y
    J Heart Lung Transplant; 2006 Apr; 25(4):404-8. PubMed ID: 16563969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.